Yogic versus conventional treatment in diarrhea-predominant irritable bowel syndrome: A randomized control study

被引:69
|
作者
Taneja, I
Deepak, KK [1 ]
Poojary, G
Acharya, IN
Pandey, RM
Sharma, MP
机构
[1] All India Inst Med Sci, Dept Physiol, New Delhi 110029, India
[2] All India Inst Med Sci, Cent Council Res Yoga & Naturopathy, New Delhi, India
[3] All India Inst Med Sci, Dept Biostat, New Delhi, India
[4] All India Inst Med Sci, Dept Gastroenterol, New Delhi, India
关键词
diarrhea-predominant irritable bowel syndrome; yogic intervention; autonomic functions; bowel symptoms; electrogastrography;
D O I
10.1023/B:APBI.0000017861.60439.95
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
This study was conducted to evaluate the comparative effect of yogic and conventional treatment in diarrhea-predominant irritable bowel syndrome (IBS) in a randomized control design. The patients were 22 males, aged 20-50 years, with confirmed diagnosis of diarrhea-predominant IBS. The conventional group (n = 12, 1 dropout) was given symptomatic treatment with loperamide 2-6 mg/day for 2 months, and the yogic intervention group ( n D 9) consisted of a set of 12 asanas ( yogic poses, i.e., Vajrasana, Shashankasana, Ushtrasana, Marjariasana, Padhastasana, Dhanurasana, Trikonasana in two variations, Pawanmuktasana, and Paschimottanasana) along with Surya Nadi pranayama ( right-nostril breathing) two times a day for 2 months. All participants were tested at three regular intervals, at the start of study - 0 month, 1 month, and 2 months of receiving the intervention - and were investigated for bowel symptoms, autonomic symptoms, autonomic reactivity ( battery of five standard tests), surface electrogastrography, anxiety profile by Spielberger's Self Evaluation Questionnaire, which evaluated trait and state anxiety. Two months of both conventional and yogic intervention showed a significant decrease of bowel symptoms and state anxiety. This was accompanied by an increase in electrophysiologically recorded gastric activity in the conventional intervention group and enhanced parasympathetic reactivity, as measured by heart rate parameters, in yogic intervention group. The study indicates a beneficial effect of yogic intervention over conventional treatment in diarrhea-predominant IBS.
引用
收藏
页码:19 / 33
页数:15
相关论文
共 50 条
  • [31] Diarrhea-predominant irritable bowel syndrome: Diagnosis, etiology, and new treatment considerations
    Lacy, Brian E.
    Moreau, Julie C.
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2016, 28 (07) : 393 - 404
  • [32] Patient satisfaction with alosetron for the treatment of women with diarrhea-predominant irritable bowel syndrome
    Olden, K
    DeGarmo, RG
    Jhingran, P
    Bagby, B
    Decker, C
    Markowitz, M
    Carter, E
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (12): : 3139 - 3146
  • [33] Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome. The SEPD perspective
    Vera, Isabel
    Judez, Javier
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2017, 109 (11) : 788 - 793
  • [34] Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review
    Mangel, Allen W.
    Hicks, Gareth A.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2012, 5 : 1 - 10
  • [35] Mesalamine Improve Symptoms of Diarrhea-Predominant Irritable Bowel Syndrome
    Bafutto, Mauro
    Bafutto, Alexandre A.
    Oliveira, Enio C.
    Rezende Filho, Joffre
    GASTROENTEROLOGY, 2013, 144 (05) : S540 - S540
  • [36] Ultrastructure of intestinal mucosa in diarrhea-predominant irritable bowel syndrome
    Zhao, D-Y
    Qi, Q-Q
    Long, X.
    Li, X.
    Chen, F-X
    Yu, Y-B
    Zuo, X-L
    PHYSIOLOGY INTERNATIONAL, 2019, 106 (03) : 225 - 235
  • [37] The Fecal Microbiome in Children With Diarrhea-Predominant Irritable Bowel Syndrome
    Michail, Sonia
    Kenche, Harshavadran
    GASTROENTEROLOGY, 2010, 138 (05) : S14 - S14
  • [38] Advancements in drug development for diarrhea-predominant irritable bowel syndrome
    Dothel, Giovanni
    Barbaro, Maria Raffaella
    Raschi, Emanuel
    Barbara, Giovanni
    De Ponti, Fabrizio
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (03) : 251 - 263
  • [39] Diagnostic Yield of Testing in Diarrhea-predominant Irritable Bowel Syndrome
    Manolakis, Catherine
    Di Palma, Jack
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S490 - S490
  • [40] A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome
    Chen, Chunqiu
    Tao, Chunhua
    Liu, Zhongchen
    Lu, Meiling
    Pan, Qiuhui
    Zheng, Lijun
    Li, Qing
    Song, Zhenshun
    Fichna, Jakub
    PHYTOTHERAPY RESEARCH, 2015, 29 (11) : 1822 - 1827